PharmaEssentia Acquires FORUS Therapeutics to Expand Canadian Commercial Operations

PharmaEssentia Corporation has acquired Canadian specialty pharmaceutical company FORUS Therapeutics in a transaction valued at $36.5 million, advancing the Taiwan-based... Read More

The post PharmaEssentia Acquires FORUS Therapeutics to Expand Canadian Commercial Operations appeared first on citybiz.